Non-Therapeutic Biomolecules Market, By Trad Pharma (Enzymes, Recombinant proteins and Plasmids), By Application (In-vitro Diagnostics and Research), By End User (Research and Pharma CRO), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Non-Therapeutic Biomolecules Market size was valued at USD 25,314.8 Million in 2023, expanding at a CAGR of 12.7% from 2024 to 2032.
Non-therapeutic biomolecules refer to biomolecules that are not directly involved in therapeutic applications or treatments. These biomolecules are important in biological systems and serve a primary function in medical or therapeutic contexts.
Non-Therapeutic Biomolecules Market- Market Dynamics
- Growing demand from diagnostic applications and biomedical engineering is expected to propel market demand
Biomolecules such as enzymes, antibodies, and proteins are essential components in diagnostic assays and devices. Advances in diagnostic technologies and increasing demand for accurate and sensitive diagnostic tests boost the market for non-therapeutic biomolecules. Thus, increasing demand from diagnostic applications is boosting the market growth. Biomolecules find extensive use in various industrial processes, including food and beverage production, cosmetics, agriculture, and environmental monitoring. Enzymes, for instance, are crucial catalysts in industrial biotechnology for manufacturing processes and waste treatment.
Biomolecules are important in biomedical engineering, especially for the creation of medication delivery systems, biomaterials, and biosensors. Their value in developing novel biomedical devices and technology arises from their capacity to interact with biological systems. Technological developments in biotechnology, genomics, proteomics, and related domains consistently enhance the potential and uses of biomolecules. The market is driven by demand since biomolecules are frequently necessary for the operation of new technologies. Non-therapeutic biomolecules also indirectly contribute to the resolution of global health issues through the creation of vaccinations, infectious disease diagnostic instruments, and environmental surveillance programs for public health.
Non-Therapeutic Biomolecules Market- Key Insights
- As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.7% over the forecast period (2024-2032)
- Based on Trad Pharma segmentation, the enzymes segment was predicted to show maximum market share in the year 2023, owing to the high demand for personalized medicines.
- Based on Application segmentation, the in vitro diagnostic (IVD) segment was the leading Application in 2023, due to the high need for non-therapeutic biomolecules in IVD solutions.
- Based on End User segmentation, the pharma research segment was the leading End User in 2023, owing to a high number of research in IVD research in the pharma sector.
- On the basis of region, North America was the leading revenue generator in 2023, owing to the developed pharma sector and the presence of top companies.
Non-Therapeutic Biomolecules Market- Segmentation Analysis:
The Global Non-Therapeutic Biomolecules Market is segmented on the basis of Trad Pharma, Application, End User, and Region.
The market is divided into three categories based on Trad Pharma: enzymes, recombinant proteins, and plasmids. The enzymes segment dominates the market. Enzyme biomolecules have greater demand from pharma industries owing to their high efficiency.
The market is divided into three categories based on Application: In-vitro diagnostic, research & development, and others. The in-vitro diagnostic segment dominates the market. The increasing demand for IVD application in biomolecular therapeutics is fueling segment growth.
The market is divided into three categories based on End User: research, pharma CRO, and others. The research segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing number of research activities in the biotechnology industry is also contributing to market growth.
Non-Therapeutic Biomolecules Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, the United States and Canada lead in biotechnology research and development, contributing to a robust market for biomolecules. Strong presence of pharmaceutical and biotech companies driving innovation in non-therapeutic applications such as diagnostics and research tools in the region. China, Japan, and South Korea are emerging as key players in the biotechnology and biomolecules markets.
Non-Therapeutic Biomolecules Market- Competitive Landscape:
The Non-Therapeutic Biomolecules market is mainly dominated by large market players. Major companies involved in non-therapeutic biomolecules include those specializing in diagnostics, research tools, and industrial applications. Top companies like Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, etc. dominate segments such as reagents, assays, and instruments used in research and diagnostics. Further, Companies invest in developing advanced technologies such as high-throughput screening systems, next-generation sequencing, and advanced imaging techniques.
Recent Developments:
- In September 2022, Akadeum Life Sciences a US-based company introduced Microbubble Leukopak Human T cell kit.
- In 2022, Eli Lily & Company completed the acquisition of Protomer Technologies for around USD 1 billion.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NON-THERAPEUTIC BIOMOLECULES MARKET KEY PLAYERS
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Agilent Technologies
- Qiagen
- PerkinElmer
- Becton, Dickinson and Company (BD)
- Hoffmann-La Roche AG
- Danaher Corporation
- Bruker Corporation
- GE Healthcare Life Sciences
- Bio-Techne Corporation
- Fluidigm Corporation
- Sartorius AG
- Eli Liliy & Company
- Illumina, Inc.
- Others
GLOBAL NON-THERAPEUTIC BIOMOLECULES MARKET, BY TRAD PHARMA- MARKET ANALYSIS, 2019-2032
- Enzymes
- Recombinant proteins
- Plasmids
GLOBAL NON-THERAPEUTIC BIOMOLECULES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- In-vitro Diagnostics
- Research
- Others
GLOBAL NON-THERAPEUTIC BIOMOLECULES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Research
- Pharma CRO
- Others
GLOBAL NON-THERAPEUTIC BIOMOLECULES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Non-Therapeutic Biomolecules Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Non-Therapeutic Biomolecules Market Snippet by Trad Pharma
2.1.2. Non-Therapeutic Biomolecules Market Snippet by Application
2.1.3. Non-Therapeutic Biomolecules Market Snippet by End User
2.1.4. Non-Therapeutic Biomolecules Market Snippet by Country
2.1.5. Non-Therapeutic Biomolecules Market Snippet by Region
2.2. Competitive Insights
3. Non-Therapeutic Biomolecules Key Market Trends
3.1. Non-Therapeutic Biomolecules Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Non-Therapeutic Biomolecules Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Non-Therapeutic Biomolecules Market Opportunities
3.4. Non-Therapeutic Biomolecules Market Future Trends
4. Non-Therapeutic Biomolecules Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Non-Therapeutic Biomolecules Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Non-Therapeutic Biomolecules Market Landscape
6.1. Non-Therapeutic Biomolecules Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Non-Therapeutic Biomolecules Market – By Trad Pharma
7.1. Overview
7.1.1. Segment Share Analysis, By Trad Pharma, 2024 & 2032 (%)
7.1.2. Enzymes
7.1.3. Recombinant proteins
7.1.4. Plasmids
8. Non-Therapeutic Biomolecules Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. In-vitro Diagnostics
8.1.3. Research
8.1.4. Others
9. Non-Therapeutic Biomolecules Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Research
9.1.3. Pharma CRO
9.1.4. Others
10. Non-Therapeutic Biomolecules Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Non-Therapeutic Biomolecules Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Non-Therapeutic Biomolecules Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Non-Therapeutic Biomolecules Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Non-Therapeutic Biomolecules Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Non-Therapeutic Biomolecules Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Trad Pharma, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Non-Therapeutic Biomolecules Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific
11.2.2. Merck KGaA
11.2.3. Bio-Rad Laboratories
11.2.4. Agilent Technologies
11.2.5. Qiagen
11.2.6. PerkinElmer
11.2.7. Becton, Dickinson and Company (BD)
11.2.8. F. Hoffmann-La Roche AG
11.2.9. Danaher Corporation
11.2.10. Bruker Corporation
11.2.11. GE Healthcare Life Sciences
11.2.12. Bio-Techne Corporation
11.2.13. Fluidigm Corporation
11.2.14. Sartorius AG
11.2.15. Eli Liliy & Company
11.2.16. Illumina, Inc.
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
